Adrian Erlebacher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adrian Erlebacher has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandar K. Stanic
Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Wisconsin–Madison , Madison, WI
5 shared publications Animal Science
USA Jan Ernerudh, Sweden
5 shared publications- Bettina Toth
351 Fairview Avenue -Ste 300, Hudson, NY 12534, USA
5 shared publications - Bor-Ching Sheu
Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan
5 shared publications Canada Kaushic
Haibin Wang, China Ana Claudia Zenclussen, Germany
5 shared publicationsCanada Kotaro Kitaya
Haibin Wang, China Ana Claudia Zenclussen, Germany
5 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 8 April 2026
- Published by Springer Nature in Nature
- Vol. 653 (8113) , 167-179
Single-cell spatiotemporal dissection of the human maternal–fetal interface
The human maternal–fetal interface is characterized by mosaic intermingling of maternal and fetal cells 1 . Yet the underlying cellular, molecular and spatial programmes remain incompletely defined. Here we generate a comprehensive atlas of the human maternal–fetal interface across normal pregnancies from early gestation to term by integrating large-scale paired single-nucleus transcriptomic and chromatin accessibility profiling with submicrometre-resolution spatial transcriptomics and CODEX multiplex protein imaging 2 , substantially boosting the spatiotemporal resolution of prior research 3 . This framework delineates common and transient cell types, states and spatial niches across the fetal and maternal compartments, reconstructs transcriptional programmes that guide cytotrophoblast and decidual stromal cell differentiation, and resolves recurrent architecture structural units that build this interface. We identify previously unrecognized arterial endothelial state transitions during cytotrophoblast-mediated spiral artery remodelling and develop a machine learning model that predicts cytotrophoblast invasiveness from transcriptomic signatures. We further discover a decidual stromal cell subtype that suppresses cytotrophoblast invasion via endocannabinoid signalling at the human maternal–fetal interface. By integrating the atlas with genome-wide association data, we pinpoint maternal and fetal cells that are most vulnerable to pre-eclampsia, preterm birth or miscarriage. This resource provides a comprehensive spatially resolved single-cell multiomic reference of the human placenta and decidua and offers a framework for decoding their normal and disordered development.
- 8 April 2026
- Published by Springer Nature in Nature
- Vol. 653 (8113) , 167-179
Top Cited PapersOpen AccessSingle-cell spatiotemporal dissection of the human maternal–fetal interface
The human maternal–fetal interface is characterized by mosaic intermingling of maternal and fetal cells 1 . Yet the underlying cellular, molecular and spatial programmes remain incompletely defined. Here we generate a comprehensive atlas of the human maternal–fetal interface across normal pregnancies from early gestation to term by integrating large-scale paired single-nucleus transcriptomic and chromatin accessibility profiling with submicrometre-resolution spatial transcriptomics and CODEX multiplex protein imaging 2 , substantially boosting the spatiotemporal resolution of prior research 3 . This framework delineates common and transient cell types, states and spatial niches across the fetal and maternal compartments, reconstructs transcriptional programmes that guide cytotrophoblast and decidual stromal cell differentiation, and resolves recurrent architecture structural units that build this interface. We identify previously unrecognized arterial endothelial state transitions during cytotrophoblast-mediated spiral artery remodelling and develop a machine learning model that predicts cytotrophoblast invasiveness from transcriptomic signatures. We further discover a decidual stromal cell subtype that suppresses cytotrophoblast invasion via endocannabinoid signalling at the human maternal–fetal interface. By integrating the atlas with genome-wide association data, we pinpoint maternal and fetal cells that are most vulnerable to pre-eclampsia, preterm birth or miscarriage. This resource provides a comprehensive spatially resolved single-cell multiomic reference of the human placenta and decidua and offers a framework for decoding their normal and disordered development.
- Open Access
- 20 June 2023
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 90 (2)
Issue Information
- 20 June 2023
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 90 (2)
Open AccessIssue Information
- Open Access
- 24 May 2023
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 90 (1)
Issue Information
- 24 May 2023
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 90 (1)
Open AccessIssue Information
- Open Access
- 17 May 2023
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 89 (6)
Issue Information
- 17 May 2023
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 89 (6)
Open AccessIssue Information
- Open Access
- 13 February 2023
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 89 (3)
Issue Information
- 13 February 2023
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 89 (3)
Open AccessIssue Information
- Open Access
- 27 January 2023
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 89 (2)
Issue Information
- 27 January 2023
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 89 (2)
Open AccessIssue Information
- Open Access
- 13 April 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (5)
Trophoblast antigens, fetal blood cell antigens, and the paradox of fetomaternal tolerance
The paradox of fetomaternal tolerance has puzzled immunologists and reproductive biologists alike for almost 70 yr. Even the idea that the conceptus evokes a uniformly tolerogenic immune response in the mother is contradicted by the long-appreciated ability of pregnant women to mount robust antibody responses to paternal HLA molecules and RBC alloantigens such as Rh(D). Synthesizing these older observations with more recent work in mice, we discuss how the decision between tolerance or immunity to a given fetoplacental antigen appears to be a function of whether the antigen is trophoblast derived—and thus decorated with immunosuppressive glycans—or fetal blood cell derived.
- 13 April 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (5)
Open AccessTrophoblast antigens, fetal blood cell antigens, and the paradox of fetomaternal tolerance
The paradox of fetomaternal tolerance has puzzled immunologists and reproductive biologists alike for almost 70 yr. Even the idea that the conceptus evokes a uniformly tolerogenic immune response in the mother is contradicted by the long-appreciated ability of pregnant women to mount robust antibody responses to paternal HLA molecules and RBC alloantigens such as Rh(D). Synthesizing these older observations with more recent work in mice, we discuss how the decision between tolerance or immunity to a given fetoplacental antigen appears to be a function of whether the antigen is trophoblast derived—and thus decorated with immunosuppressive glycans—or fetal blood cell derived.
- 2 March 2022
- Published by Springer Nature in Nature
- Vol. 603 (7901) , 497-502
Establishment of fetomaternal tolerance through glycan-mediated B cell suppression
Discrimination of self from non-self is fundamental to a wide range of immunological processes1. During pregnancy, the mother does not recognize the placenta as immunologically foreign because antigens expressed by trophoblasts, the placental cells that interface with the maternal immune system, do not activate maternal T cells2. Currently, these activation defects are thought to reflect suppression by regulatory T cells3. By contrast, mechanisms of B cell tolerance to trophoblast antigens have not been identified. Here we provide evidence that glycan-mediated B cell suppression has a key role in establishing fetomaternal tolerance in mice. B cells specific for a model trophoblast antigen are strongly suppressed through CD22–LYN inhibitory signalling, which in turn implicates the sialylated glycans of the antigen as key suppressive determinants. Moreover, B cells mediate the MHC-class-II-restricted presentation of antigens to CD4+ T cells, which leads to T cell suppression, and trophoblast-derived sialoglycoproteins are released into the maternal circulation during pregnancy in mice and humans. How protein glycosylation promotes non-immunogenic placental self-recognition may have relevance to immune-mediated pregnancy complications and to tumour immune evasion. We also anticipate that our findings will bolster efforts to harness glycan biology to control antigen-specific immune responses in autoimmune disease.
- 2 March 2022
- Published by Springer Nature in Nature
- Vol. 603 (7901) , 497-502
Establishment of fetomaternal tolerance through glycan-mediated B cell suppression
Discrimination of self from non-self is fundamental to a wide range of immunological processes1. During pregnancy, the mother does not recognize the placenta as immunologically foreign because antigens expressed by trophoblasts, the placental cells that interface with the maternal immune system, do not activate maternal T cells2. Currently, these activation defects are thought to reflect suppression by regulatory T cells3. By contrast, mechanisms of B cell tolerance to trophoblast antigens have not been identified. Here we provide evidence that glycan-mediated B cell suppression has a key role in establishing fetomaternal tolerance in mice. B cells specific for a model trophoblast antigen are strongly suppressed through CD22–LYN inhibitory signalling, which in turn implicates the sialylated glycans of the antigen as key suppressive determinants. Moreover, B cells mediate the MHC-class-II-restricted presentation of antigens to CD4+ T cells, which leads to T cell suppression, and trophoblast-derived sialoglycoproteins are released into the maternal circulation during pregnancy in mice and humans. How protein glycosylation promotes non-immunogenic placental self-recognition may have relevance to immune-mediated pregnancy complications and to tumour immune evasion. We also anticipate that our findings will bolster efforts to harness glycan biology to control antigen-specific immune responses in autoimmune disease.